NextCell Pharma at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

NextCell Pharma takes part in 2 sessions at Cell 2026 in London. Its program centres on building a quality control strategy and on the outlook for advanced therapies. That outlook weighs scientific, clinical, regulatory and economic futures for the field.

OrganizationCell 2026 Attendance
NextCell Pharma
Huddinge, Sweden
nextcellpharma.com
Biotech
Swedish company developing ProTrans, an umbilical cord stem cell therapy for type 1 diabetes, and running a cord blood bank.
Talk
Thu Nov 12
9:25am–9:50am
Developing A QC Strategy
Analytics and characterizationManufacturing and CMC
Panel
Thu Nov 12
3:05pm–3:30pm
Where Advanced Therapies Will Be In 2030: Scientific, Clinical, Regulatory & Economic Futures
with Axovia Therapeutics, BioNTech
Cell and gene therapy

Explore the full Cell 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full Cell 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from NextCell Pharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction